[February 05, 2016]

Allergic Rhinitis Pipeline Review, H2 2015 - Research and Markets

Research and Markets (http://www.researchandmarkets.com/research/q9b8x6/allergic_rhinitis) has announced the addition of the "Allergic Rhinitis - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Rhinitis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Allergic Rhinitis Overview
3. Therapeutics Development
4. Pipeline Products for Allergic Rhinitis - Overview
5. Pipeline Products for Allergic Rhinitis - Comparative Analysis
6. Allergic Rhinitis - Therapeutics under Development by Companies
7. Allergic Rhinitis - Therapeutics under Investigation by Universities/Institutes
8. Allergic Rhinitis - Pipeline Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Allergic Rhinitis - Products under Development by Companies
13. Allergic Rhinitis - Products under Investigation by Universities/Institutes
14. Allergic Rhinitis - Companies Involved in Therapeutics Development

• 3M (News - Alert) Drug Delivery Systems
• 3SBio Inc.
• Accolade Pharma LLC
• Adamis Pharmaceuticals Corporation
• AFFiRiS AG
• ALK-Abello A/S
• Ampio Pharmaceuticals, Inc.
• AnaptysBio, Inc.
• Axikin Pharmaceuticals, Inc.
• BioTech Tools s.a.
• Chong Kun Dang Pharmaceutical Corp.
• ELORAC, Inc.
• FAES Farma SA
• Fountain Biopharma Inc.
• GenMont Biotech Inc.
• GlaxoSmithKline Plc
• HAL Allergy BV
• Hanmi Pharmaceuticals, Co. Ltd.
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson
• Laboratorios LETI S.L.
• Ligand Pharmaceuticals, Inc.
• Marinomed Biotechnologie GmbH
• Merck & Co., Inc.
• Mitsubishi (News - Alert) Tanabe Pharma Corporation
• Nektar Therapeutics
• NeoPharm Co., Ltd.
• Novartis AG
• Nuvo Research Inc.
• Oxagen Limited
• Panmira Pharmaceuticals, LLC.
• Pfizer Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160205005277/en/

[ Back To TMCnet.com's Homepage ]